bioRxiv · 10.1101/2022.06.15.496255
An engineered xCas12i with high activity, high specificity and broad PAM range
Abstract
The type-V CRISPR effector Cas12i, with its smaller size, short crRNA guiding, and self-processing features, is a potentially versatile genome editing tool. By screening Cas12i proteins from a metagenomic database, we identified a natural variant with high activity in mammalian cells, named as xCas12i. We further engineered the PAM-interacting, REC, and RuvC domains for enhanced cleavage activity and specificity. This variant, named as high-fidelity Cas12Max, exhibited robust genome editing activity and minimal off-target activity with a broad 5-TN recognition profile. With the fusion of deaminase TadA8e and further optimization of xCas12i, the base editor dCas12i-Tad8e also showed the high editing efficiency. This study provides highly efficient and specific tools for gene therapy.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Zhang, H., Kong, X., Xue, M., Wang, Z., Wei, Y., Wang, H., Zhou, J., Zhang, W., Xu, M., Shen, X., Li, J., Hu, J., Zhong, N., Zhou, Y., Yang, H.. 2022-06-15. An engineered xCas12i with high activity, high specificity and broad PAM range. https://doi.org/10.1101/2022.06.15.496255
Cite the original work for its findings. Save a collection to share your selection of sources.